Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2008 June;99(3) > Minerva Medica 2008 June;99(3):241-51

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

UPDATE ON DIABETES  


Minerva Medica 2008 June;99(3):241-51

language: English

Mitochondria, body fat and type 2 diabetes: What is the connection?

Maasen J. A.

Department of Molecular Cell Biology Leiden University Medical Centre Leiden, The Netherlands


PDF  


This review will consider the concept that the development of a mitochondrial dysfunction in adipocytes is an early step in the pathogenesis for type 2 diabetes. Upon expansion of the adipose mass it becomes gradually inflamed and hypoxic. TNF-a, locally produced, induces insulin resistance of adipocytes leading to enhanced lipolysis. The excess of fatty acids, in combination with local hypoxia, results in the induction of mitochondrial damage in the adipocytes. As a result of this decline in mitochondrial activity less fatty acids can be removed within adipocytes by uncoupled mitochondrial b-oxidation and by re-esterification, as mitochondrial activity provides substrates for glyceroneogenesis. As a result these fatty acids redistribute to other compartments of the body where they are stored as ectopic triglyceride deposits. This situation is associated with the development of insulin resistance of the liver and muscle. Furthermore, it contributes to damage the pancreatic b-cells. Ultimately, this situation results in the development of a hyperglycemic state.

top of page

Publication History

Cite this article as

Corresponding author e-mail